OCEAN BIOMEDICAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

OCEAN BIOMEDICAL, INC. (OCEA) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.00% for the 0-month period ending 2023-03-29, per its 10-Q/A filed 2024-04-15.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2025-05-15

2023-03-29: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 0 month 4.00%.
2023-03-28: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 4.00%.
2023-03-19: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 0 month 4.00%.
2023-02-15: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 0 month 4.00%; Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 4.00%.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 0 month	Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
2023-03-29	4.00% 10-Q/A · filed 2024-04-15
2023-03-28		4.00% 10-Q/A · filed 2024-04-15
2023-03-19	4.00% 10-Q/A · filed 2024-04-15
2023-02-15	4.00% 10-Q/A · filed 2024-04-15	4.00% 10-Q · filed 2025-05-15
2022-09-30	2.50% 10-Q/A · filed 2024-04-15
2022-04-22	2.10% 10-Q/A · filed 2024-04-15
2022-04-20	2.10% 10-Q/A · filed 2024-04-15
2021-02-22	0.11% 10-Q/A · filed 2024-04-15